259209-20-6

Usage

Uses

suzuki reaction

InChI:InChI=1/C6H6BFO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9-11H

Upstream product

• 10294-33-4 boron tribromide 
• 179897-94-0 (5-fluoro-2-methoxyphenyl)boronic acid 
• 259209-11-5 2-(4-fluorophenoxy)tetrahydro-2H-pyran 

Downstream Products

• 1033845-01-0 methyl 6-(5-fluoro-2-hydroxyphenyl)nicotinate 
• 1086600-52-3 2-benzo[b]thiophen-7-yl-4-fluoro-phenol 
• 1262849-80-8 1-tert-butyl 3-ethyl (3R,4S)-4-(2-(5-fluoro-2-hydroxyphenyl)-6,7-dimethoxyquinazolin-4-ylamino)pyrrolidine-1,3-dicarboxylate 
• 1354819-09-2 tert-butyl ({4-[2-(2-aminopyridin-4-yl)-4-fluorophenoxy]-5-chloro-2-fluorophenyl}sulfonyl)1,3-thiazol-4-ylcarbamate 
• 1354818-85-1 4-[2-(2-aminopyridin-4-yl)-4-fluorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide 
• 1354819-30-9 tert-butyl [(5-chloro-2-fluoro-4-{4-fluoro-2-[3-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl]phenoxy}phenyl)sulfonyl]1,3-thiazol-4-ylcarbamate 
• 1354819-13-8 C₂₈H₂₈ClF₂N₅O₆S₂ 
• 1354818-92-0 4-[2-(5-amino-1H-pyrazol-4-yl)-4-fluorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide 
• 1354819-29-6 4-fluoro-2-[3-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl]phenol 
• 779331-49-6 4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol 
• 371-41-5 4-Fluorophenol 

Relevant academic research and scientific papers

19F NMR study of ligand dynamics in carboxylate-bridged dIIron(II) complexes supported by a macrocyclic ligand

A series of asymmetrically carboxylate-bridged diiron(ii) complexes featuring fluorine atoms as NMR spectroscopic probes, [Fe2(PIM)(Ar4F-PhCO2)2] (10), [Fe2(F2PIM)(ArTolCO2

Rh/Pd catalysis with chiral and achiral ligands: Domino synthesis of aza-dihydrodibenzoxepines

A game of dominoes: A synthetic route to aza-dihydrodibenzoxepines is described, through the combination of a Rh-catalyzed arylation and a Pd-catalyzed C-O coupling in a single pot. For the first time, the ability to incorporate a chiral and an achiral ligand in a two-component, two-metal transformation is achieved, giving the products in moderate to good yields, with excellent enantioselectivities. Copyright

(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors

New (3-oxo)pyridazin-4-ylurea derivatives having the chemcial structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the phosphodiesterase IV (PDE4).

2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders. Processes for preparing these inhibitors are also disclosed.

Bipyridine manganese complexes

Compounds and methods of preparing compounds represented by structural formula (I): wherein X represents any suitable counter-anion; R1and R2independently represent hydrogen, C1-6alkoxy or nitro; R3, R4/su